Addus HomeCare Corporation (ADUS) — Fair Value Analysis

Base-case fair value (P50): $121.96 · Current price: $116.06 · Verdict: Fairly Valued

The Verdict on ADUS

Our Monte Carlo simulations suggest ADDUS HOMECARE CORP (ADUS) is currently Fairly Valued. With ADUS trading at $116.06, our median fair value (P50) stands at $121.96, indicating a modest potential +5.1% upside. This implies the market's current valuation closely aligns with our data-driven estimate, leaving limited room for immediate, significant re-rating based on current fundamentals. Investors considering ADUS at $116.06 should note this equilibrium between market price and intrinsic value.

How ADUS stacks up against Healthcare

Operating within the dynamic Healthcare sector, ADUS holds an average quality tier, reflecting its operational and financial health relative to its industry peers. While the current trading price of $116.06 and our $121.96 estimate are tightly aligned, this average quality tier suggests a balanced risk-reward profile rather than a deeply discounted opportunity. The Fairly Valued verdict, supported by an average quality tier, indicates that ADUS is neither significantly under- nor over-performing in terms of valuation compared to its sector.

What this means for investors

For investors, the Fairly Valued verdict on ADUS, coupled with the modest +5.1% to our $121.96 estimate from the current $116.06, implies that the stock's present valuation largely reflects its underlying fundamentals. While a strong bull case could see the stock exceed its median fair value, investors should also consider the downside scenario given the narrow gap. The FairCurve analysis indicates that at $116.06, the market has priced in the company's expected performance, consistent with its average quality tier. Sign up for FairCurve to see the full bear/bull distribution and track ADUS's fair value as new fundamentals are released.